Newsroom

Explore our company news and media resources.

Contact us

Global Communications 
1000 Mylan Blvd. Canonsburg, PA 15317

+1. 724.514.1968
communications@viatris.com

More info

News
Apr 12, 2021

Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2021 financial results on Monday, May 10, before the open of the U.S. financial markets. The company also will host a webcast at 10...

Mar 8, 2021

Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tentative approval of budesonide/formoterol fumarate dihydrate...

Mar 4, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Barclays Global Healthcare Conference on Wednesday March 10, 2021. CEO Michael Goettler,...

Mar 1, 2021

At a virtual meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS) will outline how the company expects to lead as a new kind of healthcare company with a unique and...

Feb 22, 2021

Viatris Inc. (NASDAQ: VTRS) today announced its 2021 financial guidance and reaffirmed its commitment to rapid de-leveraging, to enhancing and growing free cash flows, particularly following the...

Browse press releases

Featured Stories

Helping to Increase Access to HIV Prevention

One of the most effective interventions in public health is Pre-Exposure Prophylaxis (PrEP) for HIV. To help address the need for more accessible options, Viatris is proud to offer a generic form of a PrEP treatment in the U.S. with the goal of expanding access for the at-risk population. 

Learn more

Featured News
Apr 7, 2021

At Viatris, we are reimagining healthcare not as it is, but as it should be.

Mar 1, 2021

Highlighting a strong foundation and clear roadmap for the future at our inaugural Investor Day, Viatris leaders showcased our journey to build a new kind of healthcare company.

Aug 5, 2020

As a leading healthcare company, Viatris is committed to doing its part in support of public health needs amid the evolving COVID-19 pandemic.

Browse articles

In the News
Nov 17, 2020
VIATRIS™ started trading today on Nasdaq, and Executive Chairman Robert J. Coury and CEO Michael Goettler shared their excitement during an interview at Nasdaq’s global Client Experience Center, located in the heart of Times Square in New York City.
Stay Connected